AstraZeneca’s Ambitious Plans For Alexion
New HQ In Kendall Square
The UK major’s CEO, Pascal Soriot, said the setting-up of a new R&D hub in Cambridge, MA, which will also serve as the new corporate headquarters for Alexion, is "a milestone moment" for the rare diseases unit.
